Contact
Professor, Faculty of Medicine & Dentistry - Biochemistry Dept
- wille@ualberta.ca
- Phone
- (780) 248-1712
- Address
-
1-10C Brain And Aging Research Building
8710 - 112 St NWEdmonton ABT6G 2M8
Overview
Area of Study / Keywords
prion amyloid protein-misfolding disease bovine spongiform encephalopathy prions genetic prions sporadic prions structure-based vaccines Alzheimer's disease Parkinson's disease
About
The general focus of my work is the structure of amyloids and other disease-related, misfolded proteins. In particular, I am interested in the infectious prion protein (PrPSc) and the structure-function relationship underlying its infectious nature. In recent years, mounting evidence has implicated prion-like mechanisms in other neurodegenerative diseases such as Alzheimer’s, Parkinson’s, and Lou Gehrig’s disease. The mechanistic similarities and their molecular underpinnings represent interesting research avenues beyond the classical prion diseases. The scope of my current experimental approaches is centered on electron microscopy, three-dimensional reconstruction approaches, X-ray fiber diffraction, and other biochemical and biophysical methods.Research
Prion structure
The molecular structure of PrPSc is one of the main unsolved questions in the prion field. Our earlier investigations using X-ray fiber diffraction (Wille et al., 2009a) indicated that the molecular architecture of PrPSc is based on a four-rung β-solenoid structure. This finding contradicted most molecular models that were proposed for the structure of PrPSc. In our most recent study (Vázquez-Fernández et al., 2016), we used electron cryomicroscopy to visualize individual PrPSc amyloid fibrils. Image processing allowed us to generate three-dimensional reconstructions of single PrPSc amyloid fibrils, which, again, revealed a four-rung β-solenoid as the basic fold for the infectious prion. Current projects focus on analyzing the structure of prion fibrils from human, animal, and recombinant sources.Structural mimics
We are also studying details about the prion protein structure itself. We want to better understand how prion protein can take on different shapes and how these shapes affect how toxic and infectious the prion protein becomes. In particular, we want to know whether the prion disease of deer and elk, Chronic Wasting Disease, may pose a risk to human health. I believe this depends a lot on what types of shapes the deer and elk prion proteins can form.Other disease-related amyloids
The techniques we developed to study the structure of PrPSc can also be applied to other disease-related misfolded proteins. In particular, we are interested in the structures of misfolded and aggregated conformers of α-synuclein, the microtubule-associated protein tau, the Alzheimer β-peptide, and many others. Comparing these structures with those of PrPSc will provide insights into the misfolding processes and how different primary structures influences higher level structural organization and aggregation.
Featured Publications
Paul P.S., Cho J.Y., Wu Q., Karthivashan G., Grabovac E., Wille H., Kulka M., Kar S.
JOURNAL OF NANOBIOTECHNOLOGY. 2022 December; 20 (1) 10.1186/s12951-022-01269-0
Anand, B, Wu, Q, Nakhaei-Nejad, M, Karthivashan, G, Dorosh, L, Amidian, S, Dahal, A, Li, X, Stepanova, M, Wille, H, Giuliani, F, Kar, S
Bioactive Materials. 2022 November; 17 https://doi.org/10.1016/j.bioactmat.2022.05.030
Daude N., Lau A., Vanni I., Kang S.G., Castle A.R., Wohlgemuth S., Dorosh L., Wille H., Stepanova M., Westaway D.
JOURNAL OF BIOLOGICAL CHEMISTRY. 2022 April; 298 (4) 10.1016/j.jbc.2022.101770
Anand B.G., Wu Q., Karthivashan G., Shejale K.P., Amidian S., Wille H., Kar S.
Bioactive Materials. 2021 December; 6 (12):4491-4505 10.1016/j.bioactmat.2021.04.029
Padilla-Camberos E., Sanchez-Hernandez I.M., Torres-Gonzalez O.R., Ramirez-Rodriguez P., Diaz E., Wille H., Flores-Fernandez J.M.
Materials. 2021 August; 14 (16) 10.3390/ma14164543
Hannaoui S., Triscott E., Velásquez C.D., Chang S.C., Arifin M.I., Zemlyankina I., Tang X., Bollinger T., Wille H., McKenzie D., Gilch S.
PLoS Pathogens. 2021 July; 17 (7) 10.1371/journal.ppat.1009795
Cortez L.M., Nemani S.K., Velásquez C.D., Sriraman A., Wang Y.L., Wille H., McKenzie D., Sim V.L.
PLoS Pathogens. 2021 June; 17 (6) 10.1371/journal.ppat.1009703
Kamali-Jamil R., Ester Vázquez-Fernández, Tancowny B., Rathod V., Amidian S., Wang X., Tang X., Fang A., Senatore A., Hornemann S., Dudas S., Aguzzi A., Young H.S., Wille H.
PLoS Pathogens. 2021 June; 17 (6) 10.1371/journal.ppat.1009628
Overduin M., Wille H., Westaway D.
CHEMISTRY AND PHYSICS OF LIPIDS. 2021 May; 236 10.1016/j.chemphyslip.2021.105063
Wu M., Dorosh L., Schmitt-Ulms G., Wille H., Stepanova M.
PLoS Computational Biology. 2021 March; 17 (3) 10.1371/journal.pcbi.1008771
Alyenbaawi H., Kanyo R., Locskai L.F., Kamali-Jamil R., Duval M.G., Bai Q., Wille H., Burton E.A., Ted Allison W.
eLife. 2021 February; 10 10.7554/eLife.58744
Ghaffari Sharaf M., Amidian S., Rathod V., Crichton A., Damji K.F., Wille H., Unsworth L.D.
Scientific Reports. 2020 December; 10 (1) 10.1038/s41598-020-72737-6
Minikel E.V., Zhao H.T., Le J., O'Moore J., Pitstick R., Graffam S., Carlson G.A., Kavanaugh M.P., Kriz J., Kim J.B., Ma J., Wille H., Aiken J., McKenzie D., Doh-Ura K., Beck M., O'Keefe R., Stathopoulos J., Caron T., Schreiber S.L., Carroll J.B., Kordasiewicz H.B., Cabin D.E., Vallabh S.M.
NUCLEIC ACIDS RESEARCH. 2020 November; 48 (19):10615-10631 10.1093/nar/gkaa616
Esmaili M., Acevedo-Morantes C., Wille H., Overduin M.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES. 2020 September; 1862 (10) 10.1016/j.bbamem.2020.183360